[go: up one dir, main page]

AR077739A1 - Tapones lagrimales - Google Patents

Tapones lagrimales

Info

Publication number
AR077739A1
AR077739A1 ARP100101012A ARP100101012A AR077739A1 AR 077739 A1 AR077739 A1 AR 077739A1 AR P100101012 A ARP100101012 A AR P100101012A AR P100101012 A ARP100101012 A AR P100101012A AR 077739 A1 AR077739 A1 AR 077739A1
Authority
AR
Argentina
Prior art keywords
plugs
tear
tear plugs
anchor
elongated
Prior art date
Application number
ARP100101012A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR077739A1 publication Critical patent/AR077739A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen tapones lagrimales adecuados para suministrar agentes terapéuticos; los tapones tienen un cuerpo, una porcion en la cual se carga el agente terapéutico, un bobinado alrededor del cuerpo, y una alargada o de anclaje en un extremo.
ARP100101012A 2009-03-31 2010-03-29 Tapones lagrimales AR077739A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16541709P 2009-03-31 2009-03-31

Publications (1)

Publication Number Publication Date
AR077739A1 true AR077739A1 (es) 2011-09-21

Family

ID=42320849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101012A AR077739A1 (es) 2009-03-31 2010-03-29 Tapones lagrimales

Country Status (14)

Country Link
US (1) US20100256578A1 (es)
EP (1) EP2413853A1 (es)
JP (1) JP2012521858A (es)
KR (1) KR20120013346A (es)
CN (1) CN102448412A (es)
AR (1) AR077739A1 (es)
AU (1) AU2010234879A1 (es)
BR (1) BRPI1014062A2 (es)
CA (1) CA2758054A1 (es)
RU (1) RU2011143792A (es)
SG (2) SG10201401086VA (es)
TW (1) TWI495459B (es)
UY (1) UY32538A (es)
WO (1) WO2010117722A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US9421127B2 (en) * 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
EP3412260B1 (en) 2009-05-18 2020-08-26 Dose Medical Corporation Drug eluting ocular implant
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259352B2 (en) * 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
JP6655610B2 (ja) 2014-05-29 2020-02-26 グローコス コーポレーション 制御された薬物送達機能を備えるインプラント及びそれを使用する方法
CN104398328A (zh) * 2014-09-30 2015-03-11 浦易（上海）生物技术有限公司 一种可完全降解的载药的鼻泪管支架及其植入系统
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN105879126A (zh) * 2016-03-24 2016-08-24 杭州亚慧生物科技有限公司 一种超润滑血清白蛋白泪点塞及其制备方法
AU2017252294B2 (en) 2016-04-20 2021-12-02 Glaukos Corporation Bioresorbable ocular drug delivery device
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
CN106491270B (zh) * 2016-12-23 2018-08-14 中国医科大学附属第一医院 一种泪点扩张装置
CN110711075A (zh) * 2018-07-11 2020-01-21 吴坚 一种泪小管栓塞
KR20230150840A (ko) 2021-02-24 2023-10-31 오큘라 테라퓨틱스, 인코포레이티드 소관내 데포 삽입 디바이스

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906551A (en) * 1974-02-08 1975-09-23 Klaas Otter Artificial intra-ocular lens system
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US4915684A (en) * 1988-06-21 1990-04-10 Mackeen Donald L Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
US4959048A (en) * 1989-01-17 1990-09-25 Helix Medical, Inc. Lacrimal duct occluder
US5334137A (en) * 1992-02-21 1994-08-02 Eagle Vision, Inc. Lacrimal fluid control device
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US6149684A (en) * 1995-06-07 2000-11-21 Herrick; Robert S. Punctum plug having a thin elongated lip and a distal starting tip and method of using
AU1727697A (en) * 1997-02-04 1998-08-25 Alain Fouere Meatus plug for lachrymal canal capable of being screwed
US6082362A (en) * 1997-03-27 2000-07-04 Eagle Vision, Inc. Punctum plug
US6041785A (en) * 1997-03-27 2000-03-28 Eaglevision, Inc. Punctum plug
US6822016B2 (en) * 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6367929B1 (en) * 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US5962548A (en) * 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6099852A (en) * 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US6629533B1 (en) * 2000-06-30 2003-10-07 Eagle Vision, Inc. Punctum plug with at least one anchoring arm
FR2829019B3 (fr) * 2001-08-31 2003-10-31 Alain Fouere Bouchons lacrymaux et methodes de mise en place de ces dispositifs
US7204253B2 (en) * 2003-05-22 2007-04-17 Clarity Corporation Punctum plug
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CA2572592C (en) * 2004-07-02 2015-09-08 Eliot Lazar Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20060276738A1 (en) * 2005-06-06 2006-12-07 Becker Bruce B Lacrimal drainage bypass device and method
US8088161B2 (en) * 2005-07-28 2012-01-03 Visioncare Ophthalmic Technologies Inc. Compressed haptics
CN103393483B (zh) * 2006-03-31 2016-08-24 玛提治疗有限公司 用于鼻泪系统的药物释放方法、结构及组合物
SG138567A1 (en) * 2006-06-21 2008-01-28 Johnson & Johnson Vision Care Punctal plugs for the delivery of active agents
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
JP2010514517A (ja) * 2006-12-26 2010-05-06 キューエルティー プラグ デリバリー，インク． 視覚欠損の抑制のための薬物送達インプラント
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
JP5555162B2 (ja) * 2007-09-07 2014-07-23 キュー エル ティー インク． 治療薬剤の持続放出のための薬物コア
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
CN104306103B (zh) * 2009-01-23 2017-04-19 马缇医疗股份有限公司 一种或多种药剂的持续释放递送
WO2010107826A2 (en) * 2009-03-16 2010-09-23 Endoshape, Inc. Reliably retained shape memory ophthal-mological implants

Also Published As

Publication number Publication date
SG174972A1 (en) 2011-11-28
KR20120013346A (ko) 2012-02-14
AU2010234879A1 (en) 2011-10-27
WO2010117722A1 (en) 2010-10-14
CA2758054A1 (en) 2010-10-14
BRPI1014062A2 (pt) 2016-04-12
RU2011143792A (ru) 2013-05-10
JP2012521858A (ja) 2012-09-20
UY32538A (es) 2010-09-30
TWI495459B (zh) 2015-08-11
TW201039805A (en) 2010-11-16
CN102448412A (zh) 2012-05-09
US20100256578A1 (en) 2010-10-07
EP2413853A1 (en) 2012-02-08
SG10201401086VA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
AR077739A1 (es) Tapones lagrimales
UY32537A (es) Tapones lagrimales
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
CL2011001811A1 (es) Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico.
CL2016002372A1 (es) Cenicriviroc para el tratamiento de la fibrosis.
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
MX382405B (es) Método para suministrar un agente activo.
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
MX2015010285A (es) Método para tratar el cabello con espuma.
CL2015003135A1 (es) Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimorficas y métodos de uso.
CL2011000916A1 (es) Uso de una combinacion de un inhibidor de proteasoma epoxicetona peptidica o una sal farmaceutica aceptable del mismo, y uno o mas de otros agentes terapeuticos para tratar el cancer.
CO6640295A2 (es) Conjunto de anclaje que incluye un anclaje expansible
DOP2012000245A (es) Composiciones sólidas
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
CL2013000718A1 (es) Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades.
CL2014001002A1 (es) Perno de anclaje en roca que incluye un cuerpo cilindrico alargado que tiene, un primer extremo distal y un segundo extremo proximal opuesto, una porcion roscada en el segundo extremo, un primer anclaje situado en o al menos parcialmente situado en una primera porcion de extremo del cuerpo, un segundo anclaje, una primera porcion de vastago entre el primer y el segundo anclaje.
IL254813B (en) Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
AR105205A1 (es) Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico
MX2015011784A (es) Dispositivo de terapia para periimplantitis.
PE20161158A1 (es) Aparato y metodo de apoyo en tierra
CL2014001468A1 (es) Un componente de cable que comprende, un cuerpo principal donde al menos una parte esta hecho de un material de aislacion, al menos una porcion no inflamable dispuesta en el material de aislacion formando al menos un 25% en volumen de dicho componente; y un cable.
SG10201902407PA (en) Injectable microparticles for hyper-localized release of therapeutic agents
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia

Legal Events

Date Code Title Description
FB Suspension of granting procedure